Research Papers

18 of 118 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome.
Willemsen S; Hartog JW; Heiner-Fokkema MR; van Veldhuisen DJ; Voors AA.
Heart Fail Rev (Unknown)
Published: 2012
1/6 Transparent
Funding Declared
Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined me…
Valle R; Aspromonte N; Milani L; Peacock FW; Maisel AS; Santini M; Ronco C.
Heart Fail Rev (Unknown)
Published: 2011
1/6 Transparent
Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes.
Bradfield J; Tung R; Boyle NG; Shivkumar K.
Heart Fail Rev (Unknown)
Published: 2011
When is an optimization not an optimization? Evaluation of clinical implications of information content (signal-to-nois…
Pabari PA; Willson K; Stegemann B; van Geldorp IE; Kyriacou A; Moraldo M; Mayet J; Hughes AD; Francis DP.
Heart Fail Rev (Unknown)
Published: 2011
1/6 Transparent
Funding Declared
Chronic ventricular pacing in children: toward prevention of pacing-induced heart disease.
van Geldorp IE; Vanagt WY; Prinzen FW; Delhaas T.
Heart Fail Rev (Unknown)
Published: 2011
Electrical modalities beyond pacing for the treatment of heart failure.
Cornelussen RN; Splett V; Klepfer RN; Stegemann B; Kornet L; Prinzen FW.
Heart Fail Rev (Unknown)
Published: 2011
Echocardiographic prediction of outcome after cardiac resynchronization therapy: conventional methods and recent develo…
Leenders GE; Cramer MJ; Bogaard MD; Meine M; Doevendans PA; De Boeck BW.
Heart Fail Rev (Unknown)
Published: 2011
Mechano-energetics of the asynchronous and resynchronized heart.
Prinzen FW; Vernooy K; De Boeck BW; Delhaas T.
Heart Fail Rev (Unknown)
Published: 2011
Aging, telomeres and heart failure.
Wong LS; van der Harst P; de Boer RA; Huzen J; van Gilst WH; van Veldhuisen DJ.
Heart Fail Rev (Unknown)
Published: 2010
1/6 Transparent
Funding Declared
Cardiomyocyte-specific inactivation of thyroid hormone in pathologic ventricular hypertrophy: an adaptative response or…
Pol CJ; Muller A; Simonides WS.
Heart Fail Rev (Unknown)
Published: 2010
Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond.
Teerlink JR; Metra M; Zacà V; Sabbah HN; Cotter G; Gheorghiade M; Cas LD.
Heart Fail Rev (Unknown)
Published: 2009
Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart.
Lehnart SE; Maier LS; Hasenfuss G.
Heart Fail Rev (Unknown)
Published: 2009
1/6 Transparent
Funding Declared
Cardiac hypertrophy and thyroid hormone signaling.
Dillmann W.
Heart Fail Rev (Unknown)
Published: 2009
Relaxin, a pleiotropic vasodilator for the treatment of heart failure.
Teichman SL; Unemori E; Dschietzig T; Conrad K; Voors AA; Teerlink JR; Felker GM; Metra M; Cotter G.
Heart Fail Rev (Unknown)
Published: 2008
Vasodilators in the treatment of acute heart failure: what we know, what we don't.
Metra M; Teerlink JR; Voors AA; Felker GM; Milo-Cotter O; Weatherley B; Dittrich H; Cotter G.
Heart Fail Rev (Unknown)
Published: 2008
The role of thyroid hormone nuclear receptors in the heart: evidence from pharmacological approaches.
Wiersinga WM.
Heart Fail Rev (Unknown)
Published: 2008
Central sleep apnea in patients with congestive heart failure.
Badr S.
Heart Fail Rev (Unknown)
Published: 2008
New insights into the importance of aminopeptidase A in hypertension.
Mizutani S; Ishii M; Hattori A; Nomura S; Numaguchi Y; Tsujimoto M; Kobayshi H; Murohara T; Wright JW.
Heart Fail Rev (Unknown)
Published: 2007